Skip to main content
TipRanks
Go Ultimate75% OFF

ASEP Medical Holdings Inc (ASEP) Stock Price & Analysis

7 Followers

ASEP Stock Chart & Stats

CA$0.10CA$0.00(0.00%)
At close: 4:00 PM EST
C$0.1C$0.2C$0.3C$0.4Aug 17Sep 3Sep 15Sep 28Oct 14Oct 27Nov 9
Day’s Range
CAD 0.10 - CAD 0.10
52-Week Range
CAD 0.06 - CAD 0.50
Previous Close
CAD 0.10
Volume
N/A
Average Volume (3M)
5,863
Market Cap
CAD 1.59M
Enterprise Value
CAD 3.93M
Total Cash (Recent Filing)
CAD 76.32K
Total Debt (Recent Filing)
CAD 177.50K
Price to Earnings (P/E)
―
Beta
-0.78
Next Earnings
Dec 01, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Very low leverage limits balance-sheet pressure while the company funds development in an early-stage biotech setting. Modest debt reduces interest and refinancing exposure, preserves financing flexibility, and gives management more room to pursue scientific and commercial milestones.

Improving Free Cash Flow

The improvement in free cash flow suggests some progress in cost control or cash-flow timing, even though the company still burns cash. If sustained, better cash discipline could extend financial runway and reduce the pace at which external funding is required.

Narrower Operating Losses

A reduction in operating losses indicates that the underlying cost structure may be moving in a better direction. Continued improvement could support eventual operating leverage as diagnostic or therapeutic programs mature, although profitability has not yet been achieved.

Bears Say

Persistent Cash Burn

Ongoing negative operating and free cash flow means the business is not currently funding itself through operations. Persistent burn can shorten financial runway, increase reliance on financing, and constrain the company’s ability to advance programs without additional capital.

Severe Unprofitability

The extremely negative margin profile shows that current revenue is far from covering the cost base. Negative gross profit and substantial losses weaken earnings quality, limit internally funded investment, and make a durable commercial model dependent on significant improvement in scale or economics.

Declining Equity Base

Declining equity alongside deeply negative returns indicates that capital is being consumed without producing adequate shareholder returns. This weakens financial resilience over time and may increase the need for future capital support as the company develops its programs.

ASEP Medical Holdings Inc News

ASEP FAQ

What was ASEP Medical Holdings Inc’s price range in the past 12 months?
ASEP Medical Holdings Inc lowest stock price was C$0.06 and its highest was C$0.50 in the past 12 months.
What is ASEP Medical Holdings Inc’s market cap?
ASEP Medical Holdings Inc’s market cap is C$1.59M.
When is ASEP Medical Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ASEP Medical Holdings Inc’s earnings last quarter?
ASEP Medical Holdings Inc released its earnings results on Jun 30, 2026. The company reported -C$0.043 earnings per share for the quarter.
Is ASEP Medical Holdings Inc overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does ASEP Medical Holdings Inc pay dividends?
ASEP Medical Holdings Inc does not currently pay dividends.
What is ASEP Medical Holdings Inc’s EPS estimate?
ASEP Medical Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ASEP Medical Holdings Inc have?
ASEP Medical Holdings Inc has 15,873,520 shares outstanding.
What happened to ASEP Medical Holdings Inc’s price movement after its last earnings report?
ASEP Medical Holdings Inc reported an EPS of -C$0.043 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ASEP Medical Holdings Inc?
Currently, no hedge funds are holding shares in TSE:ASEP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology